Mixed experiences with commercial calibrators and controls for COVID-19 drugs
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Journal of applied laboratory medicine - 7(2022), 2, Seite 617-619 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martens-Lobenhoffer, Jens [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1093/jalm/jfab130 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
1773531441 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | 1773531441 | ||
| 003 | DE-627 | ||
| 005 | 20230428030216.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 211013s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jalm/jfab130 |2 doi | |
| 035 | |a (DE-627)1773531441 | ||
| 035 | |a (DE-599)KXP1773531441 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martens-Lobenhoffer, Jens |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mixed experiences with commercial calibrators and controls for COVID-19 drugs |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 700 | 1 | |a Bode-Böger, Stefanie M. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of applied laboratory medicine |d Washington, DC : American Association for Clinical Chemistry, AACC, 2016 |g 7(2022), 2, Seite 617-619 |h Online-Ressource |w (DE-627)863735193 |w (DE-600)2863113-4 |w (DE-576)475355822 |x 2475-7241 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2022 |g number:2 |g pages:617-619 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jalm/jfab130 |x Resolving-System |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ILN_178 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_101 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_702 | ||
| 912 | |a GBV_ILN_2001 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2011 | ||
| 912 | |a GBV_ILN_2026 | ||
| 912 | |a GBV_ILN_2190 | ||
| 912 | |a GBV_ILN_4035 | ||
| 912 | |a GBV_ILN_4037 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4126 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4307 | ||
| 936 | u | w | |d 7 |j 2022 |e 2 |h 617-619 |
| 951 | |a AR | ||
| 952 | |d 7 |j 2022 |e 2 |h 617-619 | ||
| 980 | |2 178 |1 01 |x 3178 |b 3989187392 |y x |z 17-10-22 | ||
| 982 | |2 178 |1 00 |x 3178 |8 00 |0 (DE-627)504261622 |a Institut für Klinische Pharmakologie <Magdeburg> | ||
| 982 | |2 178 |1 00 |x 3178 |8 01 |a Martens-Lobenhoffer, Jens / IKP | ||
| 982 | |2 178 |1 00 |x 3178 |8 02 |a Bode-Böger, Stefanie M. / IKP | ||
| 982 | |2 178 |1 00 |x 3178 |8 03 |0 (DE-627)719906830 |a begutachteter Zeitschriftenartikel (peer reviewed) | ||
| 983 | |2 178 |1 01 |x 3178 |8 99 |a j2022 | ||